Skip to content
CancerIndex

Loading the knowledge graph…

A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastric and Colorectal Cancer Patients With FGFR Alterations Who Have Failed Standard Therapy — knowledge graph · CancerIndex